Search

Your search keyword '"Mitchenko, Olena"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Mitchenko, Olena" Remove constraint Author: "Mitchenko, Olena"
37 results on '"Mitchenko, Olena"'

Search Results

1. 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

2. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

3. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

4. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

5. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

6. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

7. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

8. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

9. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

10. The Role of Nutraceuticals in Statin Intolerant Patients

12. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

14. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

15. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

16. Abstract 12027: Low-Density Lipoprotein Cholesterol in Patients With Homozygous Familial Hypercholesterolemia Who Participated in Sequential Studies of Alirocumab and Evinacumab

17. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

18. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

19. Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

20. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

21. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

22. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)

23. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel(ILEP)

24. Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials

25. The Role of Nutraceuticals in Statin Intolerant Patients.

26. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology

27. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design

28. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

29. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

30. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes

31. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes:Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

32. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

35. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: the International ChoLesterol management Practice Study (ICLPS)

36. Evinacumab for Homozygous Familial Hypercholesterolemia

37. Worldwide experience of homozygous familial hypercholesterolaemia:retrospective cohort study

Catalog

Books, media, physical & digital resources